Paloma Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-25,248
Closed -$2.46M 2076
2020
Q3
$2.46M Buy
25,248
+436
+2% +$42.5K 0.06% 264
2020
Q2
$3.87M Buy
+24,812
New +$3.87M 0.07% 344